Walgreens Announces $683M Opioid Settlement With Florida
Walgreens Boots Alliance Inc (NASDAQ: WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.
The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal fees.
The settlement ends a trial that began on April 11, after Walgreens decided not to join a combined $878 million settlement with four other healthcare companies, including CVS Health Corp (NYSE: CVS), writes Reuters.
Walgreens did not admit to wrongdoing as part of the settlement.
Also Read: Why Walgreens Boots Alliance Shares Are Plunging Today
"I am glad that we have been able to end this monumental litigation and move past the courtroom," Florida Attorney General Ashley Moody said on Thursday during a press conference.
Florida's settlement with Walgreens came days after Washington state reached a $518 million opioid settlement with drug distributors AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corporation (NYSE: MCK).
Price Action: WBA shares are down 2.20% at $43.48 during the market session on the last check Thursday.
Photo by Diamond Rehab Thailand via Pixaby
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.